These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 2128268)

  • 21. NTP Toxicology and Carcinogenesis Studies of Iodinated Glycerol (Organidin(R).) (CAS No. 5634-39-9) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1990 Mar; 340():1-171. PubMed ID: 12724785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the genotoxic potential of Mangifera indica L. extract (Vimang), a new natural product with antioxidant activity.
    Rodeiro I; Cancino L; González JE; Morffi J; Garrido G; González RM; Nuñez A; Delgado R
    Food Chem Toxicol; 2006 Oct; 44(10):1707-13. PubMed ID: 16857303
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Dantas AD; Klein-Júnior LC; Machado MS; Guecheva TN; Dos Santos LD; Zanette RA; de Mello FB; Pêgas Henriques JA; de Mello JR
    ScientificWorldJournal; 2016; 2016():3694901. PubMed ID: 27891531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The mutagenicity evaluation of MT-141, a new cephamycin].
    Hirano F; Shindo Y; Mifune Y; Maeda H; Murata S
    Jpn J Antibiot; 1984 May; 37(5):918-26. PubMed ID: 6434763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Mutagenicity tests of suplatast tosilate (IPD-1151T)].
    Ohuchida A; Furukawa A; Sato S; Maeda Y; Kashihara A; Mizumoto T; Yoshida R
    J Toxicol Sci; 1992 May; 17 Suppl 2():207-20. PubMed ID: 1321262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genotoxic properties of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU).
    Oshiro Y; Piper CE; Soelter SG; Balwierz PS; Garriott ML
    Fundam Appl Toxicol; 1992 May; 18(4):491-8. PubMed ID: 1526360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutagenicity studies with palm fruit carotene.
    Masuda M; Haresaku M; Takei T; Nakamura T
    J Toxicol Sci; 1995 Nov; 20(5):619-27. PubMed ID: 8720168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mutagenicity studies of iodixanol, a new non-ionic isotonic contrast medium].
    Igarashi M; Nakayama S; Jones E; Shimada H
    J Toxicol Sci; 1995 Oct; 20 Suppl 1():125-31. PubMed ID: 7490784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mutagenicity studies of montirelin hydrate (NS-3)].
    Iwakura K; Tamura H; Yamashita Y; Kitayama E; Hamasu Y; Nagasawa H; Watanabe M; Sumi N
    J Toxicol Sci; 1995 Dec; 20 Suppl 2():325-34. PubMed ID: 9019565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cytotoxicity and mutagenicity studies of T-3761].
    Nakamura S; Hayashi T; Nojima Y; Nishida N; Kawamura Y; Kodama T
    Jpn J Antibiot; 1995 Jun; 48(6):868-77. PubMed ID: 7666585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro mutagenicity and cell transformation screening of phenylglycidyl ether.
    Greene EJ; Friedman MA; Sherrod JA; Salerno AJ
    Mutat Res; 1979 May; 67(1):9-19. PubMed ID: 379639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased mutagenicity of chromium compounds by nitrilotriacetic acid.
    Loprieno N; Boncristiani G; Venier P; Montaldi A; Majone F; Bianchi V; Paglialunga S; Levis AG
    Environ Mutagen; 1985; 7(2):185-200. PubMed ID: 3882415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proflavin: an unusual mutagen.
    Speck WT; Rosenkranz HS
    Mutat Res; 1980 Jan; 77(1):37-43. PubMed ID: 6987510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Failure to detect dominant-lethal mutations and effects on reproductive capacity in mice exposed to dihydroergotoxine mesylate.
    Matter BE; Tsuchimoto T; Deyssenroth H
    Arzneimittelforschung; 1978; 28(12):2286-90. PubMed ID: 582944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutagenicity of ipriflavone in vivo and in vitro.
    Belcavello L; Vencioneck Dutra JC; de Freitas JV; Aranha IP; do Carmo Pimentel Batitucci M
    Food Chem Toxicol; 2012 Mar; 50(3-4):996-1000. PubMed ID: 22200590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cerebral actions of dihydroergocristine].
    Drago F; Valerio C; Nardo L; Genazzani AA; D'Agata V; Mauceri F; Freni V
    Arzneimittelforschung; 1992 Nov; 42(11A):1391-4. PubMed ID: 1492858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutagenicity studies in a tyre plant: in vitro activity of workers' urinary concentrates and raw materials.
    Crebelli R; Paoletti A; Falcone E; Aquilina G; Fabri G; Carere A
    Br J Ind Med; 1985 Jul; 42(7):481-7. PubMed ID: 4015996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutagenicity profiles of newer amsacrine analogues with activity against solid tumours: comparison of microbial and mammalian systems.
    Ferguson LR; van Zijl P; Baguley BC
    Eur J Cancer Clin Oncol; 1989 Feb; 25(2):255-61. PubMed ID: 2649376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microbiological mutagenicity studies of pesticides in vitro.
    Carere A; Ortali VA; Cardamone G; Torracca AM; Raschetti R
    Mutat Res; 1978 Jul; 57(3):277-86. PubMed ID: 353549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genotoxic activity of the new pharmaceutical FS-1 in Salmonella/microsome test and mouse lymphoma L5178Y cells.
    Ilin A; Kulmanov M; Nersesyan A; Stopper H
    J BUON; 2015; 20(2):595-601. PubMed ID: 26011355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.